[HTML][HTML] TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome

S Merscher, B Funke, JA Epstein, J Heyer, A Puech… - Cell, 2001 - cell.com
S Merscher, B Funke, JA Epstein, J Heyer, A Puech, MM Lu, RJ Xavier, MB Demay…
Cell, 2001cell.com
Velo-cardio-facial syndrome (VCFS)/DiGeorge syndrome (DGS) is a human disorder
characterized by a number of phenotypic features including cardiovascular defects. Most
VCFS/DGS patients are hemizygous for a 1.5–3.0 Mb region of 22q11. To investigate the
etiology of this disorder, we used a cre-loxP strategy to generate mice that are hemizygous
for a 1.5 Mb deletion corresponding to that on 22q11. These mice exhibit significant
perinatal lethality and have conotruncal and parathyroid defects. The conotruncal defects …
Abstract
Velo-cardio-facial syndrome (VCFS)/DiGeorge syndrome (DGS) is a human disorder characterized by a number of phenotypic features including cardiovascular defects. Most VCFS/DGS patients are hemizygous for a 1.5–3.0 Mb region of 22q11. To investigate the etiology of this disorder, we used a cre-loxP strategy to generate mice that are hemizygous for a 1.5 Mb deletion corresponding to that on 22q11. These mice exhibit significant perinatal lethality and have conotruncal and parathyroid defects. The conotruncal defects can be partially rescued by a human BAC containing the TBX1 gene. Mice heterozygous for a null mutation in Tbx1 develop conotruncal defects. These results together with the expression patterns of Tbx1 suggest a major role for this gene in the molecular etiology of VCFS/DGS.
cell.com